Drug intelligence / Profile preview

AVT-87

Development stage: Unknown
Lead developer: Alvotech

Overview

AVT-87 is a drug candidate whose specific details, including its mechanism of action and primary indication, are not widely documented in public pharmaceutical databases or sponsor pipelines. While the 'AVT' prefix is commonly associated with biosimilar programs from Alvotech (e.g., AVT02, AVT04), AVT-87 does not appear in their current public pipeline or in major clinical trial registries. Without verifiable data from a sponsor pipeline, peer-reviewed publication, or clinical trial record, the exact nature of this compound remains unconfirmed.

Beyond the preview

Go deeper on AVT-87.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AVT-87.

Explore the full profile